Literature DB >> 25223886

Castleman disease of the neck: CT and MR imaging findings.

Xin-Hua Jiang1, Hao-Ming Song2, Qing-Yu Liu3, Yun Cao4, Guo-Hong Li1, Wei-Dong Zhang5.   

Abstract

OBJECTIVE: To characterize the computed tomography (CT) and magnetic resonance imaging (MRI) findings of Castleman disease of the neck.
METHODS: The imaging findings of 21 patients with Castleman disease of the neck were reviewed retrospectively. Of the 21 patients, 16 underwent unenhanced and contrast-enhanced CT scans; 5 underwent unenhanced and contrast-enhanced MRI scans.
RESULTS: The unenhanced CT images showed isolated or multiple well-defined homogenous mild hypodensity lesions in fifteen cases, and a heterogeneous nodule with central areas of mild hypodensity in one case. Calcification was not observed in any of the patients. In five patients, MR T1-weighted images revealed well-defined, homogeneous isointense or mild hyperintense lesions to the muscle; T2-weighted images showed these as intermediate hyperintense. Sixteen cases showed intermediate to marked homogeneous enhancement on contrast-enhanced CT or MR T1-weighted images. Of the other five cases that underwent double-phase CT scans, four showed mild or intermediate heterogeneous enhancement at the arterial phase, and homogeneous intermediate or marked enhancement at the venous phase; the remaining case showed mild and intermediate ring-enhancement with a central non-enhanced area at the arterial and venous phases, respectively.
CONCLUSION: Castleman disease of the neck can be characterized as solitary or multiple well-defined, mild hypodensity or homogeneous intense lesions on plain CT/MR scans, and demonstrates intermediate and marked enhancement on contrast-enhanced CT/MR scans. On double-phase CT scans, Castleman disease often demonstrates mild enhancement at the arterial phase, and gradually uniform enhancement at venous phase. Double-phase enhanced CT or MRI may help to differentiate Castleman disease from other diseases.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Castleman disease; Computed tomography; Magnetic resonance imaging; Neck

Mesh:

Year:  2014        PMID: 25223886     DOI: 10.1016/j.ejrad.2014.08.013

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Castleman disease of the parapharyngeal space: Diagnosis and management.

Authors:  S Jbali; S Zarraa; A Hadhri; G E F Noubbigh; S Yahyaoui; C Nasr
Journal:  Int J Surg Case Rep       Date:  2022-09-05

Review 2.  Autoimmune disease of head and neck, imaging, and clinical review.

Authors:  Alireza Paydar; Zachary B Jenner; Tyrell J Simkins; Yu-Ming Chang; Lotfi Hacein-Bey; Arzu Ozturk; Andrew Birkeland; Reza Assadsangabi; Osama Raslan; Ghazal Shadmani; Michelle Apperson; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2022-05-22

Review 3.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

4.  Castleman disease versus lymphoma in neck lymph nodes: a comparative study using contrast-enhanced CT.

Authors:  Jie Li; Jia Wang; Zhitao Yang; Hexiang Wang; Junyi Che; Wenjian Xu
Journal:  Cancer Imaging       Date:  2018-08-16       Impact factor: 3.909

5.  Castleman Disease Presenting as a Parapharyngeal Mass: A Case Report and Review of the Literature.

Authors:  David Leo Choi; Kristina Brannock; Alice L Tang
Journal:  Clin Med Insights Case Rep       Date:  2019-06-24

6.  Castleman disease in the hepatic-gastric space: A case report.

Authors:  Xiao-Yun Xu; Xue-Qing Liu; Hong-Wei Du; Jian-Hua Liu
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

7.  Ultrasound and radiological features of abdominal unicentric castleman's disease: A case series study.

Authors:  Kun Lv; Yanan Zhao; Wen Xu; Chao Zhang; Pintong Huang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.